DIAGNOSTIC METHOD FOR PROGNOSIS OF NON-SMALL-CELL LUNG CANCER USING SINGLE NUCLEOTIDE POLYMORPHISM OF PCAF

摘要

The present invention relates to a prognosis marker for lung cancer using single nucleotide polymorphism (SNP) in a P300/CBP-associated factor (PCAF) gene, and to a method for predicting the survival prognosis of lung cancer using the same. More specifically, the present invention relates to a composition for predicting the survival prognosis of lung cancer based on specific SNP existed in a promoter, an exon, and the like of PCAF genes, to a kit for the survival prognosis of lung cancer using the same, to a microarray, and to a method for predicting the survival prognosis of lung cancer.;COPYRIGHT KIPO 2016